UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
CJ HealthCare aims to add indication for Helicobacter eradication
CJ HealthCare is seeking to add an indication for the eradication of Helico...
by Lee Hye-seon
|
2018-11-07 14:58
라인
Huons completes P3 clinical trials for Hutox
Huons Global said Tuesday that it has completed domestic phase 3 clinical t...
by Lee Han-soo
|
2018-11-07 12:26
라인
Sanofi confirms continuous therapeutic benefits for relapsing-remitting multiple sclerosis treatment
Sanofi Genzyme Korea said Tuesday that it has presented a new study on Lemt...
by Lee Han-soo
|
2018-11-06 11:09
라인
LG Chem to work on bilayer tablet for diabetes, dyslipidemia
LG Chem said it would start developing bilayer tablets of Zemiro (gemiglipt...
by Lee Hye-seon
|
2018-11-06 11:06
라인
Celltrion wins suit against Roche to invalidate Herceptin patent in Japan
Korea’s biosimilar company Celltrion is likely to accelerate its move to ex...
by So Jae-hyeon
|
2018-11-05 15:26
라인
GC starts developing shingles vaccine in US
GC said Monday that its U.S. subsidiary Cuervo has received U.S. Food and D...
by Lee Han-soo
|
2018-11-05 13:31
라인
Lilly Korea’s rheumatoid arthritis treatment wins insurance coverage
Lilly Korea said Thursday that it has gained reimbursement for its rheumato...
by Lee Han-soo
|
2018-11-02 17:52
라인
Why did pharmaceuticals release hair loss drugs in tablet form?
Why have Korean pharmaceutical companies released hair loss treatments in t...
by So Jae-hyeon
|
2018-11-02 12:43
라인
Genexine wins FDA nod for clinical trials of HyLeukin-7
Genexine and NeoImmuneTech have received approval from the U.S. Food and Dr...
by Lee Han-soo
|
2018-11-01 11:03
라인
Acer submits new drug application for rare disease to FDA
Acer Therapeutics, a NASDAQ-listed pharmaceutical firm in which Bukwang Pha...
by Park Gi-taek
|
2018-10-31 15:55
라인
Korea’s drug exports to US inch down this year
Korea’s exports of pharmaceutical products to the U.S. slightly went down i...
by Nam Doo-hyun
|
2018-10-31 12:22
라인
Dong-A ST’s Q-3 sales slid to ₩140.8 billion
Dong-A ST said Tuesday that it recorded sales of 140.8 billion won ($123.5 ...
by Lee Han-soo
|
2018-10-31 11:46
라인
Hanmi’s leukemia drug candidate wins FDA’s orphan drug status
Hanmi Pharmaceutical said Wednesday that its HM43239, a drug candidate in t...
by Lee Han-soo
|
2018-10-31 11:45
라인
GC’s Q3 sales fell to ₩352.3 billion won
GC said Tuesday that the company and its subsidiaries recorded 352.3 billio...
by Lee Han-soo
|
2018-10-30 17:00
라인
[Exclusive] Patent of osteoarthritis drug Invossa refused in Europe
Kolon TissueGene has failed to obtain a patent for Korea’s 29th novel drug ...
by Nam Doo-hyun
|
2018-10-30 16:04
라인
Hanmi’s partner gets FDA nod for testing oral breast cancer treatment
Hanmi Pharmaceutical said Tuesday that Athenex, its U.S. partner, has recei...
by Lee Han-soo
|
2018-10-30 16:00
라인
Generics threaten originals in dementia drug market
Generic products are showing tremendous growth in the market of Donepezil, ...
by So Jae-hyeon
|
2018-10-30 14:18
라인
Hanmi posts ₩235.3 billion in Q3 sales
Hanmi Pharmaceutical said Monday that it recorded sales of 235.3 billion wo...
by Lee Han-soo
|
2018-10-30 11:14
라인
ViiV Healthcare asks FDA to approve new HIV treatment
ViiV Healthcare has submitted a new drug application (NDA) to the U.S. Food...
by Lee Han-soo
|
2018-10-29 16:53
라인
‘Foreign investors fear Korean botox sales decline in China’
Foreign institutional investors fear that Korean makers of botulinum toxin ...
by Nam Doo-hyun
|
2018-10-29 16:52
-
이전
61
62
63
64
65
66
67
68
69
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top